Home » Topics » Regulatory » Patents

Patents
RSS

New STING agonists identified at Tyligand Bioscience

May 17, 2022

Lhotse Bio discovers lysophosphatidic acid receptor 1 antagonists

May 17, 2022

Korea University Research and Business Foundation presents new apoptosis inducers

May 16, 2022

New compounds targeting the estrogen receptor divulged by Sanofi

May 16, 2022

Medshine Discovery patents Janus kinase inhibitors

May 16, 2022

Calithera Biosciences presents new L-amino acid oxidase inhibitors

May 16, 2022

New inhibitors of G12C mutant KRAS protein identified at Amgen

May 16, 2022

BioWorld MedTech Patent Highlights: Week 18

From Current Patent Gazette

May 13, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Chinese researchers disclose new CDK9 inhibitors

May 13, 2022

Johns Hopkins University synthesizes MAP3K12/13 inhibitors

May 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...